@article{bd4c1622a7724f9ca1abbb071cf1ade7,
title = "The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity",
abstract = "Obesity is a global epidemic leading to increased mortality and susceptibility to comorbidities, with few viable therapeutic interventions. A hallmark of disease progression is the ectopic deposition of lipids in the form of lipid droplets in vital organs such as the liver. However, the mechanisms underlying the dynamic storage and processing of lipids in peripheral organs remain an outstanding question. Here, we show an unexpected function for the major cap-binding protein, eIF4E, in high-fat-diet-induced obesity. In response to lipid overload, select networks of proteins involved in fat deposition are altered in eIF4E-deficient mice. Specifically, distinct messenger RNAs involved in lipid metabolic processing and storage pathways are enhanced at the translation level by eIF4E. Failure to translationally upregulate these mRNAs results in increased fatty acid oxidation, which enhances energy expenditure. We further show that inhibition of eIF4E phosphorylation genetically—and by a potent clinical compound—restrains weight gain following intake of a high-fat diet. Together, our study uncovers translational control of lipid processing as a driver of high-fat-diet-induced weight gain and provides a pharmacological target to treat obesity.",
author = "Conn, {Crystal S.} and Haojun Yang and Tom, {Harrison J.} and Kenji Ikeda and Oses-Prieto, {Juan A.} and Hieu Vu and Yasuo Oguri and Supna Nair and Gill, {Ryan M.} and Shingo Kajimura and DeBerardinis, {Ralph J.} and Burlingame, {Alma L.} and Davide Ruggero",
note = "Funding Information: We thank members of the Ruggero laboratory for discussion, and the Mouse Pathology, Preclinical Therapeutics, and Biomedical Imaging Core facilities at UCSF for their assistance in our study. We thank J. Blecha at UCSF for synthesis of [18F]FTHA. We thank eFFECTOR Therapeutics for supplying eFT508. We thank the VUMC Hormone Assay & Analytical Services and Lipid Core and the Children{\textquoteright}s Medical Center Research Institute at the University of Texas Southwestern Medical Center for performance and analysis of targeted metabolomics. Mass spectrometry was provided by the Mass Spectrometry Resource at UCSF (A.L. Burlingame, Director) supported by the Dr Miriam and Sheldon G. Adelson Medical Research Foundation and the UCSF Program for Breakthrough Biomedical Research. C.S.C. was funded by the American Cancer Society (no. PF-14-212-01-RMC). H.Y. is funded by the American Heart Association (no. P0540503). Y.O. is supported by the JSPS Overseas Research Fellowships. S.K. is supported by NIH (no. DK97441). D.R. is a Leukemia and Lymphoma Society Scholar. This research was funded by NIH grant nos. R01CA184624 (D.R.) and R35CA242986 (D.R.) and by the American Cancer Society RP-19-181-01-RMC (American Cancer Society Research Professor Award) (D.R.). The VUMC Cores are supported by NIH grant nos. DK059637 (MMPC) and DK020593 (DRTC). Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature Limited.",
year = "2021",
month = feb,
doi = "10.1038/s42255-021-00349-z",
language = "English (US)",
volume = "3",
pages = "244--257",
journal = "Nature Metabolism",
issn = "2522-5812",
publisher = "Springer Berlin",
number = "2",
}